Doctor profile · Federal record
Dr. Stephen Soloway, M.D.,FACP.,FACR.,Ccd
Rheumatology Physician (CMS: Rheumatology) · Vineland, NJ
- NPI 1609997873
- Accepts Medicare
- MIPS 0.0 / 100 · 2023
- 38 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2848 S Delsea Dr, Bldg 2C
Vineland, NJ 083607042
(856) 794-9090
fax (856) 794-3058 - Mailing address
-
Po Box 2697
Vineland, NJ 083622697
Credentials & registration
- NPI registered
- April 2007 — 19 yrs on file
- Profile last updated
- February 8, 2024
- Year of graduation
- 1988 — 38 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- New Jersey #25MA05934500
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1609997873. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
166,861
Distinct HCPCS
10
Medicare allowed
$3,446,304
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 52,283 | 79 | $13 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 37,806 | 124 | $33 | |
J1439 |
Injection, ferric carboxymaltose, 1 mg | 27,000 | 18 | $1 | |
J3111 |
Injection, romosozumab-aqqg, 1 mg | 17,850 | 25 | $10 | |
J0897 |
Injection, denosumab, 1 mg | 11,760 | 129 | $23 | |
J0490 |
Injection, belimumab, 10 mg | 6,870 | 11 | $50 | |
J9312 |
Injection, rituximab, 10 mg | 3,962 | 13 | $80 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 1,205 | 152 | $30 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 1,026 | 188 | $143 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 1,008 | 36 | $0 |
In context: peer comparison
Among 2 peers in Vineland Rheumatology Physician, average services per provider: 2,052. This provider delivers 81× the peer median.Open Payments
Industry payments received
All-time total
$5,798
Transactions
45
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen INC. | 7 | $5,030.55 | |
| Novartis Pharmaceuticals Corporation | 20 | $298.65 | |
| Alexion Pharmaceuticals, INC. | 3 | $134.54 | |
| Sobi, INC | 1 | $125.00 | |
| GlaxoSmithKline, LLC. | 5 | $70.03 | |
| Fresenius Kabi USA, LLC | 2 | $30.93 | |
| Pfizer INC. | 1 | $16.98 | |
| Aurinia Pharma U.S., INC. | 1 | $16.81 | |
| Genzyme Corporation | 1 | $16.53 | |
| Endo Pharmaceuticals INC. | 1 | $15.67 | |
| Ani Pharmaceuticals, INC. | 1 | $15.23 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $13.61 | |
| Ucb, INC. | 1 | $13.33 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
969
Patients
331
Total drug cost
$1,061,050
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methylprednisolone | Generic | 235 | 112 | $6,764 |
| Methotrexate (Methotrexate Sodium) | Brand | 190 | 84 | $5,544 |
| Shingrix (Varicella-Zoster Ge/As01b/Pf) | Brand | 124 | 93 | $32,080 |
| Remicade (Infliximab) | Brand | 66 | 0 | $540,913 |
| Prednisone | Generic | 57 | 24 | $740 |
| Allopurinol | Generic | 41 | 0 | $491 |
| Hydroxychloroquine Sulfate | Generic | 37 | 18 | $1,799 |
| Simponi Aria (Golimumab) | Brand | 34 | 0 | $317,808 |
| Gabapentin | Generic | 31 | 0 | $358 |
| Mycophenolate Mofetil | Generic | 29 | 0 | $2,374 |
Hospital affiliations
Frequently asked questions
What is Dr. Stephen Soloway's medical specialty?
Dr. Stephen Soloway practices Rheumatology Physician in Vineland, NJ.
Where does Dr. Stephen Soloway practice?
Dr. Stephen Soloway practices at 2848 S Delsea Dr, Vineland, NJ 083607042. Office phone: 8567949090.
What is Dr. Stephen Soloway's NPI?
Dr. Stephen Soloway's National Provider Identifier (NPI) is 1609997873, issued by NPPES.
Does Dr. Stephen Soloway accept Medicare assignment?
Yes. Dr. Stephen Soloway accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Stephen Soloway commonly perform?
Top Medicare-reported procedures in 2023: Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745); Injection, ferric carboxymaltose, 1 mg (HCPCS J1439). Source: CMS Medicare Physician & Other Practitioners file.